Oral Treatment (Medical Not Surgical) for Fibroid Tumors and Associated Bleeding
An oral medication for the treatment of heavy menstrual bleeding due to uterine fibroids. Changes in fibroid and uterine size will also be evaluated by ultrasound and/or MRI scans.
Eligible participants are: women between 18 and 49 years of age, in good general health, experiencing heavy menstrual bleeding from uterine fibroids, and willing to discontinue current hormonal treatments for the course of screening and up to one year of treatment. Study participants will be eligible to continue treatment for an additional 6 months in an open-label extension trial.
Visit https://myfibroidstudy.com for more information
Medical insurance is not required for study participation and compensation for time and travel is provided. To learn more about the study or if you’re interested in enrolling, please contact Alisha Lutat, Vanessa Lukas, or Carol Mack, PA-C at 202-293-1000.